SCHEMBL8966935

SCHEMBL8966935

COc1cccc2c(O)c(C(=O)O)ccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25B P30305 2/20 0.56
MAPT P10636 3/20 0.56
TDP1 Q9NUW8 1/20 0.56
HPGD P15428 4/20 0.54
KDM4E B2RXH2 3/20 0.54
ALDH1A1 P00352 3/20 0.54
HSD17B10 Q99714 2/20 0.54
LDHA P00338 1/20 0.50
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA7 P43166 1/20 0.50
CA9 Q16790 1/20 0.50
CA14 Q9ULX7 1/20 0.50
CYP2C9 P11712 2/20 0.49
GAA P10253 2/20 0.49
HIF1A Q16665 1/20 0.49
PLK1 P53350 1/20 0.47
HTT P42858 2/20 0.47
ESR1 P03372 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11210749 0.87 MAPT (0.60) CDC25BMAPTHPGDKDM4EALDH1A1
SCHEMBL8967035 0.83 CDC25B (0.56) CDC25BMAPTTDP1HPGDKDM4E
SCHEMBL4103770 0.82 CDC25B (0.68) CDC25BMAPTHPGDKDM4EALDH1A1
SCHEMBL29360359 0.80 MAPT (0.59) MAPTTDP1HPGDKDM4EALDH1A1
SCHEMBL5458 0.80 MAPT (0.59) MAPTTDP1HPGDKDM4EALDH1A1
SCHEMBL11963917 0.80 LDHA (0.44) CDC25BMAPTTDP1HPGDKDM4E
SCHEMBL24895097 0.80 CDC25B (0.56) CDC25BMAPTTDP1HPGDKDM4E
SCHEMBL8461417 0.80 CDC25B (0.52) CDC25BMAPTTDP1HPGDKDM4E
SCHEMBL8460917 0.80 CDC25B (0.52) CDC25BMAPTTDP1HPGDKDM4E
SCHEMBL23277173 0.79 MAPT (0.58) MAPTTDP1HPGDKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5498628-A ANTIPSYCHOTIC, PSYCHOSTIMULATORY, ANTIAUTISTIC, ANTIDEPRESSANT AND HYPOTENSIVE AGENTS, PARKINSON'S DISEASE INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) 1996-03-12 US disclosed
EP-0585116-B1 1-Alkoxy-naphthalene-2-carboxamide derivatives with high affinity for the serotonin 5-HT1A receptor LILLY INDUSTRIES LTD (GB) 1996-02-28 EP disclosed
US-5389684-A Treats disorder of central nervous system LILLY INDUSTRIES LIMITED (GB) 1995-02-14 US disclosed
EP-0585116-A1 1-Alkoxy-naphthalene-2-carboxamide derivatives with high affinity for the serotonin 5-HT1A receptor LILLY INDUSTRIES LIMITED (GB) 1994-03-02 EP disclosed
EP-0279466-B1 NOVEL NAPHTHALENE DERIVATIVES AND ANTIALLERGY AND ANTI-INFLAMMATORY PHARMACEUTICALS WARNER-LAMBERT COMPANY (US) 1993-05-19 EP disclosed
EP-0394451-A1 MUFFLER NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) 1990-10-31 EP disclosed
US-4767776-A N-1H-tetrazol-5-yl-2-naphthalene carboxamides and their use as antiallergy and antiinflammatory agents WARNER-LAMBERT COMPANY (US) 1988-08-30 US disclosed
EP-0279466-A2 Novel naphthalene derivatives and antiallergy and anti-inflammatory pharmaceuticals WARNER-LAMBERT COMPANY (US) 1988-08-24 EP disclosed
EP-0236837-A2 Mixtures of polycarbonate polysiloxane block cocondensates and thermotropic polymers, process for preparing them and their use in making mouldings, filaments, fibres and foils BAYER AG (DE) 1987-09-16 EP disclosed
EP-0232777-A2 Method of manufacturing parts of thermotropic liquid crystalline plastics with a defined orientation of the liquid crystal polymer molecule, and the parts so produced BAYER AG (DE) 1987-08-19 EP disclosed